Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Neil D. Gross; Julie E. Bauman; William E. Gooding; William Denq; Sufi M. Thomas; Lin Wang; Simion Chiosea; Brian L. Hood; Melanie Flint; Mai Sun; Thomas P. Conrads; Robert L. Ferris; Jonas T. Johnson; Kim Seungwon; Athanassios Argiris; Lori Wirth; Marina N. Nikiforova; Siegfried Jill M.; Grandis Jennifer R.

doi:10.1158/1078-0432.CCR-13-3360

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Kim Seungwon, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Siegfried Jill M., Grandis Jennifer R.

University of Brighton

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3289-3298
Number of pages	10
Journal	Clinical Cancer Research
Volume	20
Issue number	12
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-3360
Publication status	Published - 11 Apr 2014

Access to Document

10.1158/1078-0432.CCR-13-3360

Melanie Flint
- M.Flintbrighton.acuk
- School of Applied Sciences - Professor of Stress and Cancer Research
- Centre for Lifelong Health
Person: Academic

Cite this

Gross, N. D., Bauman, J. E., Gooding, W. E., Denq, W., Thomas, S. M., Wang, L., Chiosea, S., Hood, B. L., Flint, M., Sun, M., Conrads, T. P., Ferris, R. L., Johnson, J. T., Seungwon, K., Argiris, A., Wirth, L., Nikiforova, M. N., Jill M., S., & Jennifer R., G. (2014). Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer. Clinical Cancer Research, 20(12), 3289-3298. https://doi.org/10.1158/1078-0432.CCR-13-3360

@article{494c3d2176364145b546881bb59c8fcc,

title = "Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer",

author = "Gross, \{Neil D.\} and Bauman, \{Julie E.\} and Gooding, \{William E.\} and William Denq and Thomas, \{Sufi M.\} and Lin Wang and Simion Chiosea and Hood, \{Brian L.\} and Melanie Flint and Mai Sun and Conrads, \{Thomas P.\} and Ferris, \{Robert L.\} and Johnson, \{Jonas T.\} and Kim Seungwon and Athanassios Argiris and Lori Wirth and Nikiforova, \{Marina N.\} and \{Jill M.\}, Siegfried and \{Jennifer R.\}, Grandis",

year = "2014",

month = apr,

day = "11",

doi = "10.1158/1078-0432.CCR-13-3360",

language = "English",

volume = "20",

pages = "3289--3298",

journal = "Clinical Cancer Research",

issn = "1078-0432",

number = "12",

}

Gross, ND, Bauman, JE, Gooding, WE, Denq, W, Thomas, SM, Wang, L, Chiosea, S, Hood, BL, Flint, M, Sun, M, Conrads, TP, Ferris, RL, Johnson, JT, Seungwon, K, Argiris, A, Wirth, L, Nikiforova, MN, Jill M., S & Jennifer R., G 2014, 'Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer', Clinical Cancer Research, vol. 20, no. 12, pp. 3289-3298. https://doi.org/10.1158/1078-0432.CCR-13-3360

TY - JOUR

T1 - Erlotinib, Erlotinib–Sulindac versus Placebo

T2 - A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

AU - Gross, Neil D.

AU - Bauman, Julie E.

AU - Gooding, William E.

AU - Denq, William

AU - Thomas, Sufi M.

AU - Wang, Lin

AU - Chiosea, Simion

AU - Hood, Brian L.

AU - Flint, Melanie

AU - Sun, Mai

AU - Conrads, Thomas P.

AU - Ferris, Robert L.

AU - Johnson, Jonas T.

AU - Seungwon, Kim

AU - Argiris, Athanassios

AU - Wirth, Lori

AU - Nikiforova, Marina N.

AU - Jill M., Siegfried

AU - Jennifer R., Grandis

PY - 2014/4/11

Y1 - 2014/4/11

U2 - 10.1158/1078-0432.CCR-13-3360

DO - 10.1158/1078-0432.CCR-13-3360

M3 - Article

SN - 1078-0432

VL - 20

SP - 3289

EP - 3298

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 12

ER -

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Access to Document

Profiles

Melanie Flint

Cite this